Ashish Sanghrajka
About Ashish Sanghrajka
Ashish Sanghrajka is the ECM Lead at Climeworks, Strategic Advisor at Synergy3DMed, and Managing Director at Innovation Capital, with extensive experience in financial products and transactions.
Title: ECM Lead at Climeworks
Ashish Sanghrajka serves as the ECM Lead at Climeworks, a position he has held starting in 2024. In this role, he is likely involved in overseeing the company's equity capital markets activities. Climeworks is based in Zurich, Switzerland, and focuses on carbon capture technology. His role may involve strategic planning, overseeing financial operations related to capital markets, and working on initiatives to enhance the company's financial strategy.
Strategic Advisor at Synergy3DMed
Since 2021, Ashish Sanghrajka has been working as a Strategic Advisor for Synergy3DMed. Synergy3DMed operates out of New York and Tel Aviv and specializes in 3D medical technology. As a Strategic Advisor, Sanghrajka is likely providing guidance on financial and strategic matters, helping the company navigate capital markets, and advising on growth opportunities and investment strategies.
Managing Director at Innovation Capital
Ashish Sanghrajka has been acting as Managing Director at Innovation Capital since 2021. Based in New York, Innovation Capital is involved in investment management and advisory. In this capacity, Sanghrajka oversees various investment strategies, client relationships, and possibly directing the company's financial and operational activities.
Education and Expertise
Ashish Sanghrajka holds a Bachelor of Science degree in Engineering and Applied Sciences from the University of Rochester, completed in 1995. Additionally, he obtained a Certificate in Management Studies, specializing in Accounting and Finance, also from the University of Rochester. His educational background has equipped him with a comprehensive understanding of both technical and financial aspects, complementing his extensive career in investment banking and financial services.
Professional Background
Ashish Sanghrajka has an extensive professional background in investment banking and financial services. His previous roles include serving as CFO/President at Scopus Bio from 2019 to 2021, Managing Director at Mizuho Securities USA Inc. from 2011 to 2018, and Managing Director at Collins Stewart Inc. from 2010 to 2011. He also co-headed Investment Banking & Capital Markets at BIO-IB from 2002 to 2010 and held positions at DG2L Technologies, ABN AMRO Bank, and ING Barings, where he gained vast experience in managing and executing financial transactions.
Significant Transactions and Achievements
During his career, Ashish Sanghrajka has closed over 200 transactions with a total notional value exceeding $100 billion. Notably, he led the initial public offering (IPO) of a cancer immunotherapy company on the Nasdaq stock market, achieving a market capitalization of $750 million. His expertise spans various financial products, including IPOs, follow-on offerings, convertibles, private credit, margin loans, preferred equity, private placements, and equity derivatives.